Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Usability of Reusable Autoinjector for Etanercept in RA and PsA
NCT01901185Phase 3Completed
- Sponsor
- Amgen
- Start
- Jun 2013
- Primary completion
- Dec 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), psoriatic arthritis (PsA), sponsored by Amgen. Started Jun 2013; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT01901185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01901185.